Doctor profile · Federal record
Dr. SALLY DECASTRO-TILSEN, P.A.
Physician Assistant · Medical Physician Assistant · NEWPORT BEACH, CA
- NPI 1023282019
- Accepts Medicare
- 49 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
400 NEWPORT CENTER DR STE 701
NEWPORT BEACH, CA 926607608
(949) 759-8001
fax (949) 760-3671 - Mailing address
-
1101 WHITE SAILS WAY
CORONA DEL MAR, CA 926251524
Credentials & registration
- NPI registered
- April 2008 — 18 yrs on file
- Year of graduation
- 1977 — 49 yrs since
- Specialty taxonomy
- 363A00000X — NUCC code
- State license (1)
- California #PA 10296
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1023282019. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
33,408
Distinct HCPCS
4
Medicare allowed
$265,110
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0585 |
Injection, onabotulinumtoxina, 1 unit | 33,000 | 64 | $6 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 165 | 126 | $164 | |
64615 |
Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 162 | 62 | $140 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 81 | 73 | $118 |
In context: peer comparison
Among 29 peers in this city , average services per provider: 309. This provider delivers 108× the peer median.Open Payments
Industry payments received
All-time total
$11,160
Transactions
288
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 89 | $5,070.00 | |
| UCB, Inc. | 45 | $1,216.51 | |
| Teva Pharmaceuticals USA, Inc. | 31 | $920.72 | |
| Neurocrine Biosciences, Inc. | 32 | $914.92 | |
| PFIZER INC. | 24 | $438.38 | |
| Axsome Therapeutics, Inc. | 12 | $369.86 | |
| Alexion Pharmaceuticals, Inc. | 11 | $367.87 | |
| Lundbeck LLC | 8 | $316.47 | |
| Eisai Inc. | 6 | $243.35 | |
| Abbott Laboratories | 2 | $222.90 | |
| Amneal Pharmaceuticals LLC | 3 | $206.48 | |
| Lilly USA, LLC | 10 | $184.01 | |
| Collegium Pharmaceutical, Inc. | 5 | $108.43 | |
| IDORSIA PHARMACEUTICALS US INC | 5 | $90.28 | |
| Azurity Pharmaceuticals, Inc. | 5 | $80.45 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
314
Patients
52
Total drug cost
$5,157
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Gabapentin | Generic | 57 | 14 | $936 |
| Sumatriptan Succinate | Generic | 47 | 11 | $1,481 |
| Rizatriptan (Rizatriptan Benzoate) | Brand | 35 | 0 | $933 |
| Topiramate | Generic | 35 | 0 | $563 |
| Ondansetron Odt (Ondansetron) | Brand | 33 | 15 | $269 |
| Duloxetine Hcl | Generic | 25 | 0 | $436 |
| Meloxicam | Generic | 18 | 0 | $94 |
| Amitriptyline Hcl | Generic | 14 | 0 | $127 |
| Methylprednisolone | Generic | 13 | 12 | $106 |
| Ondansetron Hcl | Generic | 13 | 0 | $87 |